Association between bovine casein antibody and new onset schizophrenia among US military personnel

David W. Niebuhr, Yuanzhang Li, David N. Cowan, Natalya S. Weber, Jared A. Fisher, Glen M. Ford, Robert H Yolken

Research output: Contribution to journalArticle

Abstract

Schizophrenia is a pervasive neuropsychiatric disorder of uncertain etiology. Multiple studies have documented immune activation in individuals with schizophrenia. One antigen capable of inducing a prolonged immune response is bovine casein derived from ingested milk products. Increased levels of casein antibodies have been found in individuals with schizophrenia after diagnosis. This study was directed at determining the potential association between schizophrenia and pre-illness onset levels of immunoglobulin G (IgG) antibodies to bovine casein. Parallel analyses for casein antibody levels with bipolar disorder were included as comparison. Cases were service members who received medical discharges from the military with a schizophrenia diagnosis from 1992 to 2005. Serum specimens were selected for 855 cases and 1165 matched healthy controls. IgG antibodies to bovine whole-casein were measured by solid phase enzyme-linked immunosorbent assays (ELISAs). Hazard ratios (HR) were calculated to examine the associations of casein IgG level with risk of schizophrenia by time to diagnosis and by subjects' initial level. Increasing casein IgG antibody levels among those with a high initial level, drawn before diagnosis, was associated with an 18% increase in the hazard risk of schizophrenia per unit increase (value of low-positive standard) in IgG antibody levels (HR = 1.18; 95% CI 1.04, 1.34). This is the first report to identify an association between the risk of schizophrenia and elevated antibodies to bovine casein prior to disease onset. Additional research is required to elucidate the complex genetic environmental interactions involved in the pathogenesis of schizophrenia and to identify potentially modifiable risk factors.

Original languageEnglish (US)
Pages (from-to)51-55
Number of pages5
JournalSchizophrenia Research
Volume128
Issue number1-3
DOIs
StatePublished - May 2011

Fingerprint

Military Personnel
Caseins
Schizophrenia
Antibodies
Immunoglobulin G
Bipolar Disorder
Milk
Enzyme-Linked Immunosorbent Assay
Antigens
Serum

Keywords

  • Diet
  • Hazard ratio
  • Immunoglobulin g
  • Pre-onset
  • Serum

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Association between bovine casein antibody and new onset schizophrenia among US military personnel. / Niebuhr, David W.; Li, Yuanzhang; Cowan, David N.; Weber, Natalya S.; Fisher, Jared A.; Ford, Glen M.; Yolken, Robert H.

In: Schizophrenia Research, Vol. 128, No. 1-3, 05.2011, p. 51-55.

Research output: Contribution to journalArticle

Niebuhr, David W. ; Li, Yuanzhang ; Cowan, David N. ; Weber, Natalya S. ; Fisher, Jared A. ; Ford, Glen M. ; Yolken, Robert H. / Association between bovine casein antibody and new onset schizophrenia among US military personnel. In: Schizophrenia Research. 2011 ; Vol. 128, No. 1-3. pp. 51-55.
@article{7740472239d141b8b115c9bb8e5d6b7c,
title = "Association between bovine casein antibody and new onset schizophrenia among US military personnel",
abstract = "Schizophrenia is a pervasive neuropsychiatric disorder of uncertain etiology. Multiple studies have documented immune activation in individuals with schizophrenia. One antigen capable of inducing a prolonged immune response is bovine casein derived from ingested milk products. Increased levels of casein antibodies have been found in individuals with schizophrenia after diagnosis. This study was directed at determining the potential association between schizophrenia and pre-illness onset levels of immunoglobulin G (IgG) antibodies to bovine casein. Parallel analyses for casein antibody levels with bipolar disorder were included as comparison. Cases were service members who received medical discharges from the military with a schizophrenia diagnosis from 1992 to 2005. Serum specimens were selected for 855 cases and 1165 matched healthy controls. IgG antibodies to bovine whole-casein were measured by solid phase enzyme-linked immunosorbent assays (ELISAs). Hazard ratios (HR) were calculated to examine the associations of casein IgG level with risk of schizophrenia by time to diagnosis and by subjects' initial level. Increasing casein IgG antibody levels among those with a high initial level, drawn before diagnosis, was associated with an 18{\%} increase in the hazard risk of schizophrenia per unit increase (value of low-positive standard) in IgG antibody levels (HR = 1.18; 95{\%} CI 1.04, 1.34). This is the first report to identify an association between the risk of schizophrenia and elevated antibodies to bovine casein prior to disease onset. Additional research is required to elucidate the complex genetic environmental interactions involved in the pathogenesis of schizophrenia and to identify potentially modifiable risk factors.",
keywords = "Diet, Hazard ratio, Immunoglobulin g, Pre-onset, Serum",
author = "Niebuhr, {David W.} and Yuanzhang Li and Cowan, {David N.} and Weber, {Natalya S.} and Fisher, {Jared A.} and Ford, {Glen M.} and Yolken, {Robert H}",
year = "2011",
month = "5",
doi = "10.1016/j.schres.2011.02.005",
language = "English (US)",
volume = "128",
pages = "51--55",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Association between bovine casein antibody and new onset schizophrenia among US military personnel

AU - Niebuhr, David W.

AU - Li, Yuanzhang

AU - Cowan, David N.

AU - Weber, Natalya S.

AU - Fisher, Jared A.

AU - Ford, Glen M.

AU - Yolken, Robert H

PY - 2011/5

Y1 - 2011/5

N2 - Schizophrenia is a pervasive neuropsychiatric disorder of uncertain etiology. Multiple studies have documented immune activation in individuals with schizophrenia. One antigen capable of inducing a prolonged immune response is bovine casein derived from ingested milk products. Increased levels of casein antibodies have been found in individuals with schizophrenia after diagnosis. This study was directed at determining the potential association between schizophrenia and pre-illness onset levels of immunoglobulin G (IgG) antibodies to bovine casein. Parallel analyses for casein antibody levels with bipolar disorder were included as comparison. Cases were service members who received medical discharges from the military with a schizophrenia diagnosis from 1992 to 2005. Serum specimens were selected for 855 cases and 1165 matched healthy controls. IgG antibodies to bovine whole-casein were measured by solid phase enzyme-linked immunosorbent assays (ELISAs). Hazard ratios (HR) were calculated to examine the associations of casein IgG level with risk of schizophrenia by time to diagnosis and by subjects' initial level. Increasing casein IgG antibody levels among those with a high initial level, drawn before diagnosis, was associated with an 18% increase in the hazard risk of schizophrenia per unit increase (value of low-positive standard) in IgG antibody levels (HR = 1.18; 95% CI 1.04, 1.34). This is the first report to identify an association between the risk of schizophrenia and elevated antibodies to bovine casein prior to disease onset. Additional research is required to elucidate the complex genetic environmental interactions involved in the pathogenesis of schizophrenia and to identify potentially modifiable risk factors.

AB - Schizophrenia is a pervasive neuropsychiatric disorder of uncertain etiology. Multiple studies have documented immune activation in individuals with schizophrenia. One antigen capable of inducing a prolonged immune response is bovine casein derived from ingested milk products. Increased levels of casein antibodies have been found in individuals with schizophrenia after diagnosis. This study was directed at determining the potential association between schizophrenia and pre-illness onset levels of immunoglobulin G (IgG) antibodies to bovine casein. Parallel analyses for casein antibody levels with bipolar disorder were included as comparison. Cases were service members who received medical discharges from the military with a schizophrenia diagnosis from 1992 to 2005. Serum specimens were selected for 855 cases and 1165 matched healthy controls. IgG antibodies to bovine whole-casein were measured by solid phase enzyme-linked immunosorbent assays (ELISAs). Hazard ratios (HR) were calculated to examine the associations of casein IgG level with risk of schizophrenia by time to diagnosis and by subjects' initial level. Increasing casein IgG antibody levels among those with a high initial level, drawn before diagnosis, was associated with an 18% increase in the hazard risk of schizophrenia per unit increase (value of low-positive standard) in IgG antibody levels (HR = 1.18; 95% CI 1.04, 1.34). This is the first report to identify an association between the risk of schizophrenia and elevated antibodies to bovine casein prior to disease onset. Additional research is required to elucidate the complex genetic environmental interactions involved in the pathogenesis of schizophrenia and to identify potentially modifiable risk factors.

KW - Diet

KW - Hazard ratio

KW - Immunoglobulin g

KW - Pre-onset

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=79955483518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955483518&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2011.02.005

DO - 10.1016/j.schres.2011.02.005

M3 - Article

VL - 128

SP - 51

EP - 55

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -